Northern Trust Corp Poseida Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 565,387 shares of PSTX stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

565,387

Previous 546,296 3.49%

Holding current value

$1.62 Million

Previous $1.6 Million 1.38%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.7 - $4.04 $51,545 - $77,127	19,091 Added 3.49%	565,387 $1.62 Million
Q2 2024 Aug 14, 2024	SELL	$2.0 - $3.46 $24,198 - $41,862	-12,099 Reduced 2.17%	546,296 $1.6 Million
Q1 2024 May 14, 2024	BUY	$2.76 - $4.13 $10,650 - $15,937	3,859 Added 0.7%	558,395 $1.78 Million
Q4 2023 Feb 13, 2024	BUY	$1.83 - $3.51 $20,872 - $40,035	11,406 Added 2.1%	554,536 $1.86 Million
Q3 2023 Nov 13, 2023	BUY	$1.62 - $2.79 $53,737 - $92,547	33,171 Added 6.5%	543,130 $1.29 Million
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.4 $674,278 - $1.38 Million	406,192 Added 391.45%	509,959 $897,000
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $56,367 - $159,767	18,301 Added 21.41%	103,767 $319,000
Q4 2022 Feb 13, 2023	BUY	$3.33 - $6.38 $67,592 - $129,501	20,298 Added 31.15%	85,466 $452,000
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $36,260 - $67,298	14,922 Added 29.7%	65,168 $231,000
Q2 2022 Aug 12, 2022	SELL	$1.87 - $5.0 $353,510 - $945,215	-189,043 Reduced 79.0%	50,246 $129,000
Q1 2022 May 13, 2022	SELL	$3.22 - $7.04 $40,262 - $88,028	-12,504 Reduced 4.97%	239,289 $1.07 Million
Q4 2021 Feb 08, 2022	SELL	$6.23 - $7.6 $32,819 - $40,036	-5,268 Reduced 2.05%	251,793 $1.72 Million
Q3 2021 Nov 15, 2021	BUY	$7.09 - $10.71 $85,023 - $128,434	11,992 Added 4.89%	257,061 $1.87 Million
Q2 2021 Aug 13, 2021	BUY	$7.96 - $10.07 $633,966 - $802,015	79,644 Added 48.15%	245,069 $2.46 Million
Q1 2021 May 12, 2021	BUY	$8.51 - $11.91 $27,487 - $38,469	3,230 Added 1.99%	165,425 $1.58 Million
Q4 2020 Feb 11, 2021	SELL	$8.29 - $11.7 $44,392 - $62,653	-5,355 Reduced 3.2%	162,195 $1.78 Million
Q3 2020 Nov 16, 2020	BUY	$8.09 - $16.25 $1.36 Million - $2.72 Million	167,550 New	167,550 $1.49 Million

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $245M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Poseida Therapeutics, Inc. Transaction History